Bernalillo County Isleta Boulevard Corridor Project slated to begin in fall 2025
BERNALILLO COUNTY, N.M. (KRQE) — The next phase of the Isleta Boulevard Corridor Project was approved by the Bernalillo County Board of Commissioners on Tuesday evening. The project aims to make improvements to the corridor from Mapais Road SW to Luchetti Road SW from Isleta Boulevard.
Story continues below
New Mexico Insiders: Leader Of Albuquerque FBI Steps Down
Trending: Family of 105-year-old Bataan Death March survivor shares his story
Crime: New Mexico correctional officer caught by husband for bringing drugs to inmate, court docs show
Community: Poll: Where is the best place to go camping in New Mexico?
The project includes new pavements, buffered bike lanes, landscaping/irrigation, traffic signals with adaptive signalization controls, Intelligent Transportation Systems (ITS), lighting, pavement markings, signage and a wider ADA compliant sidewalk. The funding for construction is $11,500,000 in total. $2,990,400 is in federal funding, $8,000,000 in State House Bill 2 funds, and $509,600 in county matching funds.
'This project has been in the works for several years due to antiquated infrastructure,' said Commissioner Frank Baca in a news release. 'This represents a substantial investment in the safety of our roadways and sidewalks. I would like to thank the state and federal governments for their contributions. I look forward to the startup date and community members will be made fully aware of any changes to traffic patterns as it progresses.'
Construction is slated to begin in fall 2025. It will take at least 18 months to complete.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
14 hours ago
- Yahoo
H.C. Wainwright Reaffirms Vertex Buy Rating After ADA Conference Results
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) ranks among the best fundamental stocks to buy according to hedge funds. With a price target of $550, H.C. Wainwright reaffirmed its Buy rating on Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) on June 23. The update comes after the American Diabetes Association (ADA) conference featured updated data from Vertex's zimislecel program. According to the clinical findings, 10 out of 12 patients, or 83% of the total, became insulin independent. Furthermore, as evidence of the treatment's potential efficacy, H.C. Wainwright reported that all research participants achieved primary composite endpoints with sustained C-peptide restoration. Notably, as Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) seeks to expand its therapeutic areas, the zimislecel program represents a component of the company's pipeline beyond its primary cystic fibrosis therapies. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is a global biotechnology company that is involved in the discovery and development of small-molecule medications for the treatment of severe illnesses, including cystic fibrosis. While we acknowledge the potential of VRTX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. Read More: and Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
20 hours ago
- Yahoo
Truist Reiterates Eli Lilly (LLY) Buy Rating on Orforglipron Diabetes Drug Data
Eli Lilly and Company (NYSE:LLY) is one of the 12 stocks that will make you rich in 10 years. On June 23, Truist Securities reiterated its 'Buy' rating on Eli Lilly stock. The firm also maintained the price target of $1,038.00. Truist's move followed Eli Lilly's presentation at the American Diabetes Association (ADA) 85th Annual Meeting. Pixabay/Public Domain The rating pertains to Eli Lilly's oral diabetes drug, orforglipron (OFG), evaluated in the Phase 3 ACHIEVE-1 study for Type 2 diabetes treatment. The ACHIEVE-1 study results were presented at the ADA conference, showcasing orforglipron's efficacy and safety profile. The trial demonstrated statistically significant reductions in A1C (a long-term blood sugar metric) and body weight compared to placebo, with efficacy increasing at higher doses. Truist's analysis was informed by attending the orforglipron presentation, gathering feedback from KOLs at the ADA conference, and participating in Eli Lilly's investor event, where management provided clarity to alleviate safety concerns. The firm noted that longer-term data are required to further strengthen orforglipron's safety profile, particularly for chronic use in diabetes and potential obesity indications. Eli Lilly and Company (NYSE:LLY) is an American global biopharmaceutical company. The company discovers, develops, and markets prescription medicines for diabetes, obesity, cancer, immunological disorders, and neurological diseases. Its key products include Mounjaro, Zepbound, Trulicity, Verzenio, Taltz, and Jardiance. While we acknowledge the potential of LLY as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure: None.
Yahoo
3 days ago
- Yahoo
Study Finds Foreclosure and Recession Fears Point to Housing Slowdown
Five-year high: Calls from homeowners to lawyers about foreclosure surge More than 70 percent of homeowners and buyers worry a recession and tariffs will derail homeownership plans 44 percent of homeowners regret not using a lawyer during the homebuying process to protect their asset ADA, Okla., June 27, 2025--(BUSINESS WIRE)--Legal requests related to foreclosures have reached their highest level in five years, coinciding with a new LegalShield survey showing that more than 70 percent of homeowners and prospective buyers worry that a potential recession and tariffs could disrupt their housing plans. LegalShield also saw a marked drop in inquiries related to home purchases and housing construction, suggesting a potential slowdown in the overall housing market. "The hard data from consumers calling lawyers matches their fears about the economy: their homes are at risk and things may get worse," said Warren Schlichting, LegalShield CEO. "The other concerning finding is a drop in consumers asking for help to buy a home and a decline in questions from builders." Foreclosure Surge Reflects Mounting Economic Strain Calls to LegalShield provider lawyers about foreclosures spiked in May to the highest level since April 2020. "Our data highlights a convergence of pressures: buyers from the homebuying surge a few years ago want help with rising insurance premiums, property tax reassessments, and adjustable-rate mortgage resets," said Matt Layton, senior vice president of consumer analytics. "People are reaching out to LegalShield provider lawyers to save their homes, and they're scared of the next shoe to drop in the economy." Signs of the Times: Home Sales and Construction Inquiries Sink In a potential sign of a coming slowdown in housing transactions and construction, LegalShield saw significant declines in inquiries about buying and selling existing homes and home building. LegalShield fields approximately 150,000 calls monthly from consumers nationwide covering more than 90 areas of law, including real estate-related issues. In May, legal activity related to housing sales fell to its lowest level since July 2023, the last time the Federal Reserve raised interest rates. Both buyers and sellers face mounting friction amid affordability challenges due to mortgage rate uncertainty, elevated home prices and inventory challenges. LegalShield's Housing Construction Index, which tracks closely with Housing Starts reported by the U.S. Census Bureau, is now at its lowest level since March 2020 and down 4.1% this year suggesting a potential slowdown in new home building. Legal Problems Driving Buyers Away The nationwide survey, conducted in May, found that over a third of current homeowners (38%) experience costly legal issues related to their property, and 30% of all respondents have walked away from buying a home due to preventable legal problems. Homeowners say they regret not consulting an attorney in their homebuying process (44%). "Perhaps now more than ever, consumers need to consider how to protect themselves and their asset if they are able to buy a home in the midst of these economic headwinds," said Schlichting. "Instead of calling a lawyer after something goes wrong, smart homeowners are starting to get legal advice upfront—before they buy, before they renovate, before problems become expensive disasters." The LegalShield survey was conducted in May 2025 and surveyed 802 adults, ages 25-80, who live in the United States. The sample was balanced by age, among other demographic variables, according to the U.S. Census. About LegalShield: For more than 50 years, LegalShield has provided everyday Americans with easy and affordable access to legal advice, counsel, protection, and representation. Serving millions, LegalShield is one of the world's largest platforms for legal, identity, and reputation management services protecting individuals and businesses across North America. Founded in 1972, LegalShield, and its privacy management product, IDShield, has provided individuals, families, businesses, and employers with tools and services needed to affordably live a just and secure life. Through technology and innovation, LegalShield is disrupting the traditional legal system and transforming how and where people receive legal guidance and services, with access to hundreds of qualified, trusted attorneys and law firms. LegalShield and IDShield are products of Pre-Paid Legal Services, Inc. To learn more about LegalShield and IDShield, visit and View source version on Contacts LegalShield Media Contact: Hollon Kohtz, Director of Communicationshollonkohtz@ Sign in to access your portfolio
